Literature DB >> 27262345

Dysfunctional stress responses in chronic pain.

Alain Woda1, Pascale Picard2, Frédéric Dutheil3.   

Abstract

Many dysfunctional and chronic pain conditions overlap. This review describes the different modes of chronic deregulation of the adaptive response to stress which may be a common factor for these conditions. Several types of dysfunction can be identified within the hypothalamo-pituitary-adrenal axis: basal hypercortisolism, hyper-reactivity, basal hypocortisolism and hypo-reactivity. Neuroactive steroid synthesis is another component of the adaptive response to stress. Dehydroepiandrosterone (DHEA) and its sulfated form DHEA-S, and progesterone and its derivatives are synthetized in cutaneous, nervous, and adipose cells. They are neuroactive factors that act locally. They may have a role in the localization of the symptoms and their levels can vary both in the central nervous system and in the periphery. Persistent changes in neuroactive steroid levels or precursors can induce localized neurodegeneration. The autonomic nervous system is another component of the stress response. Its dysfunction in chronic stress responses can be expressed by decreased basal parasympathethic activity, increased basal sympathetic activity or sympathetic hyporeactivity to a stressful stimulus. The immune and genetic systems also participate. The helper-T cells Th1 secrete pro-inflammatory cytokines such as IL-1-β, IL-2, IL-6, IL-8, IL-12, IFN-γ, and TNF-α, whereas Th2 secrete anti-inflammatory cytokines: IL-4, IL-10, IGF-10, IL-13. Chronic deregulation of the Th1/Th2 balance can occur in favor of anti- or pro-inflammatory direction, locally or systemically. Individual vulnerability to stress can be due to environmental factors but can also be genetically influenced. Genetic polymorphisms and epigenetics are the main keys to understanding the influence of genetics on the response of individuals to constraints.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute; Autonomic nervous system; Chronic; Disease; Environment; Physiopathology

Mesh:

Substances:

Year:  2016        PMID: 27262345     DOI: 10.1016/j.psyneuen.2016.05.017

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  27 in total

1.  Clinical Pain-related Outcomes and Inflammatory Cytokine Response to Pain Following Insomnia Improvement in Adults With Knee Osteoarthritis.

Authors:  Kathi L Heffner; Christopher R France; Lisham Ashrafioun; Maria Quiñones; Patrick Walsh; Michael D Maloney; Brian D Giordano; Wilfred R Pigeon
Journal:  Clin J Pain       Date:  2018-12       Impact factor: 3.442

2.  Associations Between Perceived Stress and Chemotherapy-Induced Peripheral Neuropathy and Otoxicity in Adult Cancer Survivors.

Authors:  Christine Miaskowski; Steven M Paul; Judy Mastick; Gary Abrams; Kimberly Topp; Betty Smoot; Kord M Kober; Margaret Chesney; Melissa Mazor; Grace Mausisa; Mark Schumacher; Yvette P Conley; Jennifer Henderson Sabes; Steven Cheung; Margaret Wallhagen; Jon D Levine
Journal:  J Pain Symptom Manage       Date:  2018-03-07       Impact factor: 3.612

3.  Hearing loss and tinnitus in survivors with chemotherapy-induced neuropathy.

Authors:  Christine Miaskowski; Steven M Paul; Judy Mastick; Mark Schumacher; Yvette P Conley; Betty Smoot; Gary Abrams; Kord M Kober; Steven Cheung; Jennifer Henderson-Sabes; Margaret Chesney; Melissa Mazor; Margaret Wallhagen; Jon D Levine
Journal:  Eur J Oncol Nurs       Date:  2017-11-07       Impact factor: 2.398

4.  Impact of chemotherapy-induced neurotoxicities on adult cancer survivors' symptom burden and quality of life.

Authors:  Christine Miaskowski; Judy Mastick; Steven M Paul; Gary Abrams; Steven Cheung; Jennifer Henderson Sabes; Kord M Kober; Mark Schumacher; Yvette P Conley; Kimberly Topp; Betty Smoot; Grace Mausisa; Melissa Mazor; Margaret Wallhagen; Jon D Levine
Journal:  J Cancer Surviv       Date:  2017-11-20       Impact factor: 4.442

5.  Dialectical Pain Management: Feasibility of a Hybrid Third-Wave Cognitive Behavioral Therapy Approach for Adults Receiving Opioids for Chronic Pain.

Authors:  Deborah Barrett; Carrie E Brintz; Amanda M Zaski; Mark J Edlund
Journal:  Pain Med       Date:  2021-05-21       Impact factor: 3.750

Review 6.  The interaction between stress and chronic pain through the lens of threat learning.

Authors:  Inge Timmers; Conny W E M Quaedflieg; Connie Hsu; Lauren C Heathcote; Cynthia R Rovnaghi; Laura E Simons
Journal:  Neurosci Biobehav Rev       Date:  2019-10-14       Impact factor: 8.989

Review 7.  Effects of joint and nerve mobilisation on neuroimmune responses in animals and humans with neuromusculoskeletal conditions: a systematic review and meta-analysis.

Authors:  Ivo J Lutke Schipholt; Michel W Coppieters; Onno G Meijer; Nefeli Tompra; Rob B M de Vries; Gwendolyne G M Scholten-Peeters
Journal:  Pain Rep       Date:  2021-06-03

8.  The Need for Objective Measures of Stress in Autism.

Authors:  Cédric Hufnagel; Patrick Chambres; Pierre R Bertrand; Frédéric Dutheil
Journal:  Front Psychol       Date:  2017-01-27

9.  Stress and salivary cortisol in emergency medical dispatchers: A randomized shifts control trial.

Authors:  Sarah Bedini; François Braun; Laurence Weibel; Michel Aussedat; Bruno Pereira; Frédéric Dutheil
Journal:  PLoS One       Date:  2017-05-15       Impact factor: 3.240

10.  DHEA as a Biomarker of Stress: A Systematic Review and Meta-Analysis.

Authors:  Frédéric Dutheil; Sarah de Saint Vincent; Bruno Pereira; Jeannot Schmidt; Farès Moustafa; Morteza Charkhabi; Jean-Baptiste Bouillon-Minois; Maëlys Clinchamps
Journal:  Front Psychiatry       Date:  2021-07-06       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.